-
1
-
-
0033869563
-
Flucytosine: A review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
-
Vermes, A., Guchelaar, A.J., Dankert, J.: Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J. Antimicrob. Chemother. 46, 171-179 (2000)
-
(2000)
J. Antimicrob. Chemother.
, vol.46
, pp. 171-179
-
-
Vermes, A.1
Guchelaar, A.J.2
Dankert, J.3
-
2
-
-
0001354595
-
Industrial applications of cyclodextrins
-
Hedges, A.R.: Industrial applications of cyclodextrins. Chem. Rev. 98, 2035-2044 (1998)
-
(1998)
Chem. Rev.
, vol.98
, pp. 2035-2044
-
-
Hedges, A.R.1
-
3
-
-
0029819323
-
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization
-
Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017-1025 (1996)
-
(1996)
J. Pharm. Sci.
, vol.85
, pp. 1017-1025
-
-
Loftsson, T.1
Brewster, M.E.2
-
4
-
-
43949084749
-
Inclusion complexes of Sulconazole with β-cyclodextrin and hydroxypropyl β-cyclodextrin: Characterization in aqueous solution and in solid state
-
doi: 10.1007/s10847-007-9391-3
-
Spulber, M., Pinteala, M., Harabagiu, V., Simionescu, B.C. Inclusion complexes of Sulconazole with β-cyclodextrin and hydroxypropyl β-cyclodextrin: characterization in aqueous solution and in solid state. J. Incl. Phenom. Macro. doi: 10.1007/s10847-007-9391-3
-
J. Incl. Phenom. Macro.
-
-
Spulber, M.1
Pinteala, M.2
Harabagiu, V.3
Simionescu, B.C.4
-
6
-
-
0026564314
-
Evolving role of flucytosine in immunocompromised patients: New insights into safety, pharmacokinetics, and antifungal therapy
-
Francis, P., Walsh, T.J.: Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. Clin. Infect. Dis. 15, 1003-1018 (1992)
-
(1992)
Clin. Infect. Dis.
, vol.15
, pp. 1003-1018
-
-
Francis, P.1
Walsh, T.J.2
-
7
-
-
0028943101
-
Flucytosine-what is its future?
-
Viviani, M.A.: Flucytosine-what is its future? J. Antimicrob. Chemother. 35, 241-244 (1995)
-
(1995)
J. Antimicrob. Chemother.
, vol.35
, pp. 241-244
-
-
Viviani, M.A.1
-
9
-
-
27744547950
-
Diclofenac-β-cyclodextrin binary systems: Physicochemical characterization and in vitro dissolution and diffusion studies
-
3
-
Manca, M.L., Zaru, M., Ennas, G., Valenti, D., Sinico, C., Loy, G., Fadda, A.M.: Diclofenac-β-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies. AAPS PharmSciTech. 6(3), 464-472 (2005)
-
(2005)
AAPS PharmSciTech.
, vol.6
, pp. 464-472
-
-
Manca, M.L.1
Zaru, M.2
Ennas, G.3
Valenti, D.4
Sinico, C.5
Loy, G.6
Fadda, A.M.7
-
10
-
-
27744575591
-
Cyclodextrins in drug delivery: Un updated review
-
2
-
Chala, R., Ahuja, A., Ali, J., Khar, R.K.: Cyclodextrins in drug delivery: un updated review. AAPS PharmSciTech. 6(2), 329-357 (2005)
-
(2005)
AAPS PharmSciTech.
, vol.6
, pp. 329-357
-
-
Chala, R.1
Ahuja, A.2
Ali, J.3
Khar, R.K.4
-
11
-
-
23144440785
-
Triamterene-β-cyclodextrin systems: Preparation, characterization and in vivo evaluation
-
1
-
Mukne, A.P., Nagarsenker, M.S.: Triamterene-β-cyclodextrin systems: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 5(1), 83-90 (2004)
-
(2004)
AAPS PharmSciTech.
, vol.5
, pp. 83-90
-
-
Mukne, A.P.1
Nagarsenker, M.S.2
-
12
-
-
0034982724
-
Molecular modeling study of β- And γ-cyclodextrin complexes with miconazole
-
Piel, G., Dive, G., Ervard, B., Van Hees, T., Henry de Hassonville, S., Delattre, L.: Molecular modeling study of β- and γ-cyclodextrin complexes with miconazole. Eur. J. Pharm. Sci. 13, 271-279 (2001)
-
(2001)
Eur. J. Pharm. Sci.
, vol.13
, pp. 271-279
-
-
Piel, G.1
Dive, G.2
Ervard, B.3
Van Hees, T.4
Henry De Hassonville, S.5
Delattre, L.6
-
13
-
-
0842265765
-
Separation of purine and pyrimidine bases by capillary electrophoresis using β-cyclodextrin as an additive
-
6
-
Wang, P., Jeng, R.: Separation of purine and pyrimidine bases by capillary electrophoresis using β-cyclodextrin as an additive. J. Pharm. Biomed. Anal. 9(6), 277-283 (2004)
-
(2004)
J. Pharm. Biomed. Anal.
, vol.9
, pp. 277-283
-
-
Wang, P.1
Jeng, R.2
-
14
-
-
0842286014
-
Unusual covalent bond-breaking reactions of β-cyclodextrin inclusion complexes of nucleobases/nucleosides and related guest molecules
-
6
-
Vrkic, A., O'Hair, R.A.J.: Unusual covalent bond-breaking reactions of β-cyclodextrin inclusion complexes of nucleobases/nucleosides and related guest molecules. Eur. J. Mass. Spectrom. 9(6), 563-577 (2003)
-
(2003)
Eur. J. Mass. Spectrom.
, vol.9
, pp. 563-577
-
-
Vrkic, A.1
O'Hair, R.A.J.2
-
15
-
-
34047242245
-
Preparation and physicochemical characterization of omeprazole: Methyl-beta-cyclodextrin inclusion complex in solid state
-
Figueiras, A., Ribeiro, L., Vieira, M.T., Veiga, E.F.: Preparation and physicochemical characterization of omeprazole: methyl-beta-cyclodextrin inclusion complex in solid state. J Incl Phenom Macrocycl Chem. 57, 173-177 (2007)
-
(2007)
J Incl Phenom Macrocycl Chem.
, vol.57
, pp. 173-177
-
-
Figueiras, A.1
Ribeiro, L.2
Vieira, M.T.3
Veiga, E.F.4
-
16
-
-
0028924778
-
Study of the dissolution characteristics of oxazepam via complexation with β-cyclodextrin
-
Moyano, J.R., Gine's, J.M., Arias, M.J., Rabasco, A.M.: Study of the dissolution characteristics of oxazepam via complexation with β-cyclodextrin. Int. J. Pharm. 114, 95-102 (1995)
-
(1995)
Int. J. Pharm.
, vol.114
, pp. 95-102
-
-
Moyano, J.R.1
Gine'S, J.M.2
Arias, M.J.3
Rabasco, A.M.4
|